Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single‐institution experience
Evan C. Chen(Dana-Farber Cancer Institute), Aric Parnes(Brigham and Women's Hospital), Paula Temoczko(Brigham and Women's Hospital), William J. Gibson(Broad Institute), Nathan T. Connell(Brigham and Women's Hospital), Robert I. Handin(Brigham and Women's Hospital)
Cited by 14
Related Papers
BET Bromodomain Inhibition of <i>MYC</i> -Amplified Medulloblastoma
|Clinical Cancer Research|2013|354
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism
|Nature Genetics|2016|282
Genomic landscape of high-grade meningiomas
|npj Genomic Medicine|2017|212
Landscape of Genomic Alterations in Pituitary Adenomas
|Clinical Cancer Research|2016|136
VTE in ICU Patients With COVID-19
|CHEST Journal|2020|92